SCHEMBL6501538

SCHEMBL6501538

O=C(O)CC1SC(Nc2ccccc2F)=NC1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
KDM4E B2RXH2 3/20 0.46
NSD2 O96028 1/20 0.46
GAA P10253 1/20 0.46
GLA P06280 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CXCL8 P10145 1/20 0.45
PTGDR2 Q9Y5Y4 1/20 0.41
ALDH1A1 P00352 4/20 0.40
EGFR P00533 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
C1R P00736 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6386592 0.84 MAPT (0.43) MAPTKDM4ENSD2GAACXCL8
SCHEMBL6505857 0.82 MAPT (0.45) MAPTKDM4ENSD2GAAGLA
SCHEMBL6387862 0.79 KDM4E (0.45) MAPTKDM4ENSD2GAAALDH1A1
SCHEMBL6506396 0.79 P2RX7 (0.45) MAPTKDM4ENSD2GAAALDH1A1
SCHEMBL1605897 0.78 MAPT (0.46) MAPTKDM4EHSD17B10ALDH1A1MEN1
SCHEMBL6506320 0.76 L3MBTL1 (0.47) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL1606403 0.74 DGAT1 (0.38) MAPTKDM4ENSD2GAACXCL8
SCHEMBL1383748 0.73 HSD11B1 (0.39) MAPTKDM4ENSD2GAAALDH1A1
SCHEMBL21067474 0.73 HSD11B1 (0.39) MAPTKDM4ENSD2GAAALDH1A1
SCHEMBL31419781 0.73 HSD11B1 (0.39) MAPTKDM4ENSD2GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239853-A1 New compounds BIOVITRUM AB (SE) 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239853-A1 New compounds HSD11B1, CYP11B1, HSD3B1 MAPT 3607/4885KDM4E 2824/4885NSD2 3021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.